Critically ill COVID-19 sub phenotypes and differential treatment effects - RB&HH Education Skip to the content
Log in Register
Login
  • Events
  • Expert talks
    • Grand rounds
  • Courses
  • Clinical training
    • Clinical training
    • Clinical fellowships
    • Clinical observerships
    • Other training opportunities
  • About us
    • About us
    • Our specialists
    • News
    • FAQs
  • Events
  • Expert talks
    • Grand rounds
  • Courses
  • Clinical training
    • Clinical training
    • Clinical fellowships
    • Clinical observerships
    • Other training opportunities
  • About us
    • About us
    • Our specialists
    • News
    • FAQs
  • LOG IN
  • REGISTER
  • Login

Critically ill COVID-19 sub phenotypes and differential treatment effects

Critically ill COVID-19 sub phenotypes and differential treatment effects
Professor Manu Shankar-Hari
1 hour
Critically ill COVID-19 sub phenotypes and differential treatment effects 1 Topic
Module Content
0% Complete 0/1 Steps
not-completed
Critically ill COVID-19 sub phenotypes and differential treatment effects
Watch the Expert Talk by clicking the link above.
Access talk FREE

Curated for

Radiographers / technologists & Secondary care doctors & Tertiary care doctors

Subject

Respiratory medicine

Duration

1 hour

Certified:

CPD
EXPERT TALK
Overview

Professor Manu Shankar Hari provides an overview of recently published work on the preliminary data on validation of critically ill COVID-19 patients.

CONTENT
Learning objectives
  • Review phenotypes and endotypes
  • Review method and results of recent paper; who was studied, what was measured and subphenotypes
  • Gain knowledge of treatment effect differences
  • Review the strengths and limitations of the cohort
EXPERT
Professor Manu Shankar Hari

Professor Manu Shankar Hari is the chair of translational critical care medicine at the University of Edinburgh.

His research goal is to enable precision immunomodulation in critically ill adults, with a core hypothesis that modifiable networks generate clinical phenotypes, and such networks could be determined by integration of clinical and immunobiology data.

Would you like to know more?

Please get in touch with our team who will be able to assist you.

Contact us
Register
  • Events
  • Expert talks
  • Courses
  • About us
  • FAQs
  • Privacy Policy
  • Terms and Conditions
  • Cookies Policy
  • Contact us
  • Guy’s and St Thomas’ Specialist Care
  • Royal Brompton & Harefield Hospitals
  • Royal Brompton & Harefield Hospitals Alumni Network
Register

To the top ↑ Up ↑

© 2025 Guy's and St Thomas' NHS Foundation Trust

Twitter LinkedIn
Log In
Accessing this course requires a login. Please enter your credentials below!

Forgotten your password?
Register
Don't have an account? You can register for one.
Register for an account

Registration confirmation will be emailed to you.